Effect of a single-dose of olanzapine on sleep in healthy females and males

被引:47
作者
Lindberg, N
Virkkunen, M
Tani, R
Appelberg, B
Virkkala, J
Rimón, R
Porkka-Heiskanen, T
机构
[1] Univ Helsinki, Dept Physiol, Inst Biomed, Helsinki 00290, Finland
[2] Finnish Inst Occupat Hlth, Helsinki, Finland
[3] Univ Helsinki, Dept Psychiat, Helsinki, Finland
关键词
gender differences; healthy subjects; power spectrum; olanzapine; schizophrenia; sleep;
D O I
10.1097/00004850-200207000-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of a single dose of 10 mg olanzapine on healthy volunteers of both sexes was examined using polysomnography and power spectral analysis. The structure and continuity of sleep were unaffected by olanzapine in both sexes. The increase in both actual sleep time and slow wave sleep in females correlated with the increase in theta power, while delta power was not significantly elevated, suggesting that theta power may be a sensitive indicator of changes in sleep. The changes in sleep had the same tendency in men, but they were not significant. The difference between the sexes could not be explained by differences in body mass index. Olanzapine affects sleep probably through 5-HT2C receptors. The receptor gene is located on the X-chromosome, inducing an allelic difference between the females and males. This difference may contribute to the different effects of olanzapine on sleep. Olanzapine seems to preserve the normal structure of sleep and increase the amount of slow-wave sleep, which might be of additional benefit in treatment of schizophrenia. The effective clinical dose may be lower for females than males. Int Clin Psychopharmacol 17177-184 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 44 条
[31]   BRAIN-STEM NEUROMODULATION AND REM-SLEEP [J].
MCCARLEY, RW ;
GREENE, RW ;
RAINNIE, D ;
PORTAS, CM .
SEMINARS IN THE NEUROSCIENCES, 1995, 7 (05) :341-354
[32]   A PET study of 5-HT2 and D-2 dopamine receptor occupancy induced by olanzapine in healthy subjects [J].
Nyberg, S ;
Farde, L ;
Halldin, C .
NEUROPSYCHOPHARMACOLOGY, 1997, 16 (01) :1-7
[33]  
Poolsup N, 2000, J CLIN PHARM THER, V25, P197
[34]  
Rechtschaffen A., 1968, BRAIN INFORM SERVICE
[35]   Olanzapine: A novel atypical neuroleptic agent [J].
Reus, VI .
LANCET, 1997, 349 (9061) :1264-1265
[36]   THE ROLE OF ACTIGRAPHY IN THE EVALUATION OF SLEEP DISORDERS [J].
SADEH, A ;
HAURI, PJ ;
KRIPKE, DF ;
LAVIE, P .
SLEEP, 1995, 18 (04) :288-302
[37]   Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency [J].
Salin-Pascual, RJ ;
Herrera-Estrella, M ;
Galicia-Polo, L ;
Laurrabaquio, MR .
BIOLOGICAL PSYCHIATRY, 1999, 46 (01) :141-143
[38]   Olanzapine increases slow-wave sleep:: Evidence for blockade of central 5-HT2C receptors in vivo [J].
Sharpley, AL ;
Vassallo, CM ;
Cowen, PJ .
BIOLOGICAL PSYCHIATRY, 2000, 47 (05) :468-470
[39]   EFFECT OF PHARMACOLOGICAL TREATMENTS ON THE SLEEP OF DEPRESSED-PATIENTS [J].
SHARPLEY, AL ;
COWEN, PJ .
BIOLOGICAL PSYCHIATRY, 1995, 37 (02) :85-98
[40]   Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine [J].
Sharpley, AL ;
Vassallo, CM ;
Pooley, EC ;
Harrison, PJ ;
Cowen, PJ .
PSYCHOPHARMACOLOGY, 2001, 153 (02) :271-272